Vivek Asati - Concepedia

Author

Vivek Asati

Indo Soviet Friendship College of Pharmacy ORCID

Also Known As

Abuzer Ali, Asati Vivek, Asati, Vivek, VIVEK ASATI, Vikas Asati, Vivek Asati, Vivek asati

151

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Indo Soviet Friendship College of Pharmacy Guru Ghasidas Vishwavidyalaya Dr. Hari Singh Gour University Taif University

About

Vivek Asati is an author at Indo Soviet Friendship College of Pharmacy specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	20	479
2	Natural Sciences	11	11	269
3	Biochemistry	8	8	201
4	Engineering	2	2	59
5	Biomedical Engineering	1	1	10

Vivek Asati

Publications

568

Citations

H-Index

Page 1

	Year	Citations
Furan and benzofuran derivatives as privileged scaffolds as anticancer agents: SAR and docking studies (2010 to till date) Preeti Patel, Ruchi Shakya, vishakha vishakha, Journal of Molecular Structure Medicinal ChemistryPharmaceutical SciencePrivileged ScaffoldsBenzofuran DerivativesMedicine	2023	51
Design, synthesis and molecular modeling studies of novel thiazolidine-2,4-dione derivatives as potential anti-cancer agents Vivek Asati, Sanjay Kumar Bharti Journal of Molecular Structure Combinatorial ChemistryMedicinal ChemistryEngineeringMedicineDrug Discovery	2017	48
Design, synthesis and antidiabetic study of triazole clubbed indole derivatives as α-glucosidase inhibitors Ritu Ritu, Priyanka Sharma, Ghanshyam Das Gupta, Bioorganic Chemistry Medicinal ChemistryPharmaceutical Scienceα-Glucosidase InhibitorsBiochemistryAntidiabetic Study	2023	34
Inhibition performances of new pyrazole derivatives against the corrosion of C38 steel in acidic medium: Computational study Savaş Kaya, Farhan Siddique, Konstantin P. Katin, Results in Surfaces and Interfaces	2024	31
Integrated computational approach on sodium-glucose co-transporter 2 (SGLT2) Inhibitors for the development of novel antidiabetic agents Sushanta Bhattacharya, Vivek Asati, Mitali Mishra, Journal of Molecular Structure BiochemistryMedicineNatural SciencesDiabetesRational Drug Design	2020	30
Virtual Screening, Molecular Docking, and DFT Studies of Some Thiazolidine‐2,4‐diones as Potential PIM‐1 Kinase Inhibitors Vivek Asati, Santosh Singh Thakur, Neeraj Upmanyu, ChemistrySelect Drug TargetHit IdentificationMolecular BiologyChemical BiologyDft Studies	2018	28
An insight on medicinal attributes of pyrimidine scaffold: An updated review Akshun Vyas, Bhaskar Sahu, Shelly Pathania, Journal of Heterocyclic Chemistry Pharmaceutical ScienceBioorganic ChemistryPyrimidine RingsPharmacotherapyMedicinal Attributes	2022	27
Identification of potential N-substituted 5-benzylidenethiazolidine-2,4‑dione derivatives as α-amylase inhibitors: Computational cum synthetic studies Shankar Gupta, Gurkaran Singh Baweja, Vivek Asati Journal of Molecular Structure Medicinal ChemistryDerivativesBiochemistryNatural SciencesMedicine	2023	27
3D-QSAR and virtual screening studies of thiazolidine-2,4-dione analogs: Validation of experimental inhibitory potencies towards PIM-1 kinase Vivek Asati, Sanjay Kumar Bharti, Ashok Kumar Budhwani Journal of Molecular Structure Thiazolidine-2,4-dione AnalogsMedicinal ChemistryPim-1 KinaseVirtual Screening StudiesDrug Target	2016	26
Computational approaches for the design of novel dopamine D2 and serotonin 5-HT2A receptor dual antagonist towards schizophrenia Akash Rathore, Vivek Asati, Mitali Mishra, In Silico Pharmacology PsychiatryFunctional SelectivityComputational ApproachesNovel Dopamine D2Medicine	2022	26

Page 1